investordatabase.org

venBio Partners LLC

venbio.com Direct investor

venBio is a life sciences investment firm founded in 2011, with venture funds comprising nearly $1.1 billion in committed capital. It focuses on novel therapeutics for unmet medical needs and partners with industry leaders to build medicines and technologies.

venBio Partners LLC is a venture capital firm headquartered in San Francisco, United States, founded in 2011. It invests directly in companies, from seed to Series C and later, in life sciences, novel therapeutics and biotech. $1.1 billion under management, as it reports.

“We are a life sciences investment firm partnering with industry leaders to build game-changing medicines and technologies with a focus on novel therapeutics for unmet medical needs.”

venBio Partners LLC, own website
Layer
Direct investor
Type
Venture capital
Stage
SeedSeries C+
Headquarters
San Francisco, United States
Sectors
life sciences, novel therapeutics, biotech
Founded
2011
Assets under management
$1.1 billion

Team, as venBio Partners LLC publishes it

  • Corey Goodman Co-founder and Managing Partner
  • Aaron Royston Managing Partner
  • Richard Gaster Managing Partner
  • Yvonne Yamanaka Partner
  • Parthiv Patel Analyst
  • Robert Adelman Co-founder and Emeritus Managing Partner
  • David Pezeshki Chief Financial Officer
  • Daniel Teichmann Controller

Names and roles exactly as listed on venbio.com. Nothing else about these people is recorded.

Co-invests most often with

Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 97 co-investors found.

and 87 more — the graph.

Where this comes from

Every fact above was read from a page venBio Partners LLC publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 3070 · added 2026-09-03 · link last verified 2026-09-06 · confidence high

Similar investors

Listed under